Mj. Koury et al., APOPTOSIS OF LATE-STAGE ERYTHROBLASTS IN MEGALOBLASTIC-ANEMIA - ASSOCIATION WITH DNA-DAMAGE AND MACROCYTE PRODUCTION, Blood, 89(12), 1997, pp. 4617-4623
An in vitro model of folate-deficient erythropoiesis has been develope
d using proerythroblasts isolated from the spleens of Friend virus-inf
ected mice fed an amino acid-based, folate-free diet. Control proeryth
roblasts were obtained from Friend virus-infected mice fed the same di
et plus 2 mg folic acid/kg diet. Our previous studies showed that, aft
er 20 to 32 hours of culture in folate-deficient medium with 4 U/mL of
erythropoietin, the folate-deficient proerythroblasts underwent apopt
osis, whereas control erythroblasts survived and differentiated into r
eticulocytes over a period of 48 hours, The addition of folic acid or
thymidine to the folate-deficient medium prevented the apoptosis of th
e folate-deficient erythroblasts, thereby implicating decreased thymid
ylate synthesis as the main cause of apoptosis in the folate-deficient
erythroblasts, In the study reported here, we examined intracellular
folate levels, uracil misincorporation into DNA, p53 and p21 proteins,
and reticulocyte formation in erythroblasts cultured in folate-defici
ent or control medium. In all experiments, the folate-deficient erythr
oblasts cultured in folate-deficient medium gave results that varied s
ignificantly from folate-deficient erythroblasts cultured in control m
edium or control erythroblasts cultured in either folate-deficient or
control media. Folate-deficient erythroblasts cultured in folate-defic
ient medium had marked decreases in all coenzyme forms of folate that
persisted throughout culture, increased uracil misincorporation into D
NA, persistent accumulations of p53 and p21, and decreased reticulocyt
e production but increased size of individual reticulocytes, A model o
f folate-deficient erythropoiesis based on apoptosis of late stage ery
throblasts is presented. This model provides explanations for the clin
ical findings in megaloblastic anemia. (C) 1997 by The American Societ
y of Hematology.